Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Diltiazem hydrochloride extended release 180mg capsule, USP (Ingenus Pharmaceuticals , LLC)
Section 19A approved medicine
(Approval lapsed) Diltiazem hydrochloride extended release 180mg capsule, USP (Ingenus Pharmaceuticals , LLC)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
VASOCARDOL CD diltiazem hydrochloride 180mg capsule bottle - ARTG 68922
Indication(s)
- For the treatment of hypertension.
- For the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. Since the safety and efficacy of CD capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.
Images
